433 related articles for article (PubMed ID: 11567228)
1. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
Fanburg-Smith JC; Miettinen M
Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
[TBL] [Abstract][Full Text] [Related]
2. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
Mentzel T; Schärer L; Kazakov DV; Michal M
Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
[TBL] [Abstract][Full Text] [Related]
3. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
[TBL] [Abstract][Full Text] [Related]
4. Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors.
Perosio PM; Brooks JJ
Am J Pathol; 1988 Jul; 132(1):152-60. PubMed ID: 2456020
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
Kovarik CL; Hsu MY; Cockerell CJ
J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
[TBL] [Abstract][Full Text] [Related]
6. Dermatofibrosarcoma protuberans: a tumour of nestin-positive cutaneous mesenchymal stem cells?
Sellheyer K; Nelson P; Krahl D
Br J Dermatol; 2009 Dec; 161(6):1317-22. PubMed ID: 19659472
[TBL] [Abstract][Full Text] [Related]
7. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
Sjöblom T; Shimizu A; O'Brien KP; Pietras K; Dal Cin P; Buchdunger E; Dumanski JP; Ostman A; Heldin CH
Cancer Res; 2001 Aug; 61(15):5778-83. PubMed ID: 11479215
[TBL] [Abstract][Full Text] [Related]
9. Fine-needle aspiration of primary and recurrent dermatofibrosarcoma protuberans.
Klijanienko J; Caillaud JM; Lagacé R
Diagn Cytopathol; 2004 Apr; 30(4):261-5. PubMed ID: 15048962
[TBL] [Abstract][Full Text] [Related]
10. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors.
Weiss SW; Langloss JM; Enzinger FM
Lab Invest; 1983 Sep; 49(3):299-308. PubMed ID: 6310227
[TBL] [Abstract][Full Text] [Related]
11. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
Lazova R; Tantcheva-Poor I; Sigal AC
J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
[TBL] [Abstract][Full Text] [Related]
12. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma.
Mori T; Misago N; Yamamoto O; Toda S; Narisawa Y
J Dermatol; 2008 Jul; 35(7):419-25. PubMed ID: 18705829
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution.
Hornick JL; Fletcher CD
Am J Clin Pathol; 2002 Feb; 117(2):188-93. PubMed ID: 11865845
[TBL] [Abstract][Full Text] [Related]
14. New entities, concepts, and questions in childhood tumor pathology.
Harms D
Gen Diagn Pathol; 1995 May; 141(1):1-14. PubMed ID: 8542501
[TBL] [Abstract][Full Text] [Related]
15. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
Labonte S; Hanna W; Bandarchi-Chamkhaleh B
J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors.
Palman C; Bowen-Pope DF; Brooks JJ
Lab Invest; 1992 Jan; 66(1):108-15. PubMed ID: 1309926
[TBL] [Abstract][Full Text] [Related]
17. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
18. p63 immunohistochemical staining is limited in soft tissue tumors.
Jo VY; Fletcher CD
Am J Clin Pathol; 2011 Nov; 136(5):762-6. PubMed ID: 22031315
[TBL] [Abstract][Full Text] [Related]
19. Human neoplastic Schwann cells: changes in the expression of neurotrophins and their low-affinity receptor p75.
Bonetti B; Panzeri L; Carner M; Zamboni G; Rizzuto N; Moretto G
Neuropathol Appl Neurobiol; 1997 Oct; 23(5):380-6. PubMed ID: 9364463
[TBL] [Abstract][Full Text] [Related]
20. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
